Dr Lalchandani Labs Ltd.
Snapshot View

26.80 ▼0%

30 September 2022, 04:00:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.lalchandanipathlab.com
Market Cap 11.61 Cr.
Enterprise Value(EV) 12.76 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 2.15 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 12.46 Trailing Twelve Months Ending 2022-03
Industry PE 49.82 Trailing Twelve Months Ending 2022-03
Book Value / Share 22.01 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.22 Calculated using Price: 26.80
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.43 Cr. 4,333,068 Shares
FaceValue 10
Company Profile
They are a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through their integrated network, they offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-0.74%
1 Month
+3.88%
3 Month
+12.13%
6 Month
-18.79%
1 Year
+3.88%
2 Year
+157.69%
5 Year
10 Year
4 years 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 8.11 9.85 6.01 11.56
Return on Capital Employed (%) 10.06 12.57 9.17 14.88
Return on Assets (%) 4.23 6.53 4.30 7.46

Balance Sheet View Details >>

Particulars 4 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 3 8 9 10
Non Curr. Liab. 1 1 2 3
Curr. Liab. 2 1 2 3
Minority Int.
Equity & Liab. 6 10 12 15
Non Curr. Assets 2 4 4 6
Curr. Assets 4 6 8 9
Misc. Exp. not W/O 0 0 0 0
Total Assets 6 10 12 15

Profit Loss View Details >>

Particulars 4 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 3 5 6 10
Other Income 0 0
Total Income 3 5 6 10
Total Expenditure -2 -4 -5 -8
PBIDT 1 1 1 2
Interest 0 0 0 0
Depreciation 0 0 0 -1
Taxation 0 0 0 0
Exceptional Items
PAT 0 1 0 1
Adjusted EPS 1 1 1 2

Cash Flow View Details >>

Particulars 4 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 1
Cash Fr. Inv. -1 -2 -1 -2
Cash Fr. Finan. 2 4 1 2
Net Change 1 1 0 1
Cash & Cash Eqvt 1 2 2 3

Shareholding Pattern View Details >>

9 Qtrs 2017-03 (%) 2018-09 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%)
Promoter 89.80 60.78 60.78 60.78 60.78 60.78 60.78 60.78 60.78
Public 10.20 39.22 39.22 39.22 39.22 39.22 39.22 39.22 39.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
We wish to inform you that the members of the company at their 05th Annual General Meeting held on Friday 30th September 2022 at 03:00 p.m and concluded at 06:10 p.m at the 1st Floor 19C Club Road Punjabi Bagh West New Delhi - 110026 have transacted and voted on all the items of business as mentioned in notice of AGM.
Fri, 30 Sep 2022
Proceedings At 05Th Annual General Meeting Of The Company Held On 30Th September 2022.
We hereby submit summary of proceedings of the 05th Annual General Meeting of Dr. Lalchandani Labs Limited held on Friday 30th September 2022 at 03:00 p.m at 1st Floor 19C Club Road Punjabi Bagh West New Delhi - 110026
Thu, 08 Sep 2022
Fixes Book Closure For AGM
Pursuant to Section 91 of the Companies Act 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Register of Members and Share Transfer books will remain closed from Wednesday September 21 2022 to Friday September 30 2022 (both days inclusive) for the purpose of the forthcoming 05th Annual General Meeting.

Technical Scans View Details >>

Fri, 30 Sep 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 951.55 +0.3%
Divi's Laboratories Ltd. 97,811.90 3,750.00 +1.2%
Cipla Ltd. 89,996.82 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. 52,506.43 1,586.85 +1.7%
Abbott India Ltd. 40,438.70 19,029.40 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-06 36.17 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-06 50.01 19,029.40 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-06 4.19 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-06 13.56 19,029.40 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-03 0.00 19,029.40 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-03 29.95 19,029.40 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-03 29.95 19,029.40 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,029.40 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 951.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,750.00 +1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,140.10 +2.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,407.60 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,403.20 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,586.85 +1.7%
Abbott India Ltd. Standalone 2022-03 798.70 19,029.40 -0.6%

FAQ's On Dr Lalchandani Labs Ltd.

What is Dr Lalchandani Labs share price?

Can I buy Dr Lalchandani Labs shares now?

What is the Market Cap of Dr Lalchandani Labs?

What are the key metrics to analyse Dr Lalchandani Labs?

What is the 52 Week High and Low of Dr Lalchandani Labs?